Vancomycin versus Linezolid in the Treatment of Methicillin-Resistant Staphylococcus aureus Meningitis


SİPAHİ O. R. , BARDAK-OZCEM S., Turhan T. , ARDA B. , RUKSEN M., PULLUKÇU H. , ...Daha Fazla

SURGICAL INFECTIONS, cilt.14, ss.357-362, 2013 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 14 Konu: 4
  • Basım Tarihi: 2013
  • Doi Numarası: 10.1089/sur.2012.091
  • Dergi Adı: SURGICAL INFECTIONS
  • Sayfa Sayıları: ss.357-362

Özet

Background: Vancomycin is the mainstay of treatment for methicillin-resistant Staphylococcus aureus (MRSA) meningitis. However, successful outcomes with linezolid have not been reported in a large series of patients. We conducted a single-center retrospective cohort study to compare vancomycin with linezolid in the treatment of MRSA meningitis.